116 related articles for article (PubMed ID: 38677730)
1. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
Samukawa Y; Ouchi Y; Miyashita T; Rahman A; Tsukamoto I; Yoshihara A; Hoshikawa H
Anticancer Res; 2024 May; 44(5):1895-1903. PubMed ID: 38677730
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of D-allose: up-regulation of thioredoxin-interacting protein in head and neck cancer cells.
Hoshikawa H; Mori T; Mori N
Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):567-71. PubMed ID: 20860283
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the radiation effects by D-allose in head and neck cancer cells.
Hoshikawa H; Indo K; Mori T; Mori N
Cancer Lett; 2011 Jul; 306(1):60-6. PubMed ID: 21439723
[TBL] [Abstract][Full Text] [Related]
4. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with D-allose, docetaxel and radiation inhibits the tumor growth in an
Hoshikawa H; Kamitori K; Indo K; Mori T; Kamata M; Takahashi T; Tokuda M
Oncol Lett; 2018 Mar; 15(3):3422-3428. PubMed ID: 29456721
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Tohi Y; Taoka R; Zhang X; Matsuoka Y; Yoshihara A; Ibuki E; Haba R; Akimitsu K; Izumori K; Kakehi Y; Sugimoto M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743212
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of head and neck carcinomas by D-allose.
Mitani T; Hoshikawa H; Mori T; Hosokawa T; Tsukamoto I; Yamaguchi F; Kamitori K; Tokuda M; Mori N
Head Neck; 2009 Aug; 31(8):1049-55. PubMed ID: 19340872
[TBL] [Abstract][Full Text] [Related]
8. Effects of D-allose in combination with docetaxel in human head and neck cancer cells.
Indo K; Hoshikawa H; Kamitori K; Yamaguchi F; Mori T; Tokuda M; Mori N
Int J Oncol; 2014 Nov; 45(5):2044-50. PubMed ID: 25109398
[TBL] [Abstract][Full Text] [Related]
9. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
[TBL] [Abstract][Full Text] [Related]
10. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
Malm SW; Hanke NT; Gill A; Carbajal L; Baker AF
J Exp Clin Cancer Res; 2015 Apr; 34(1):31. PubMed ID: 25888489
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
[TBL] [Abstract][Full Text] [Related]
13. D-allose: Molecular Pathways and Therapeutic Capacity in Cancer.
Khajeh S; Ganjavi M; Panahi G; Zare M; Zare M; Tahami SM; Razban V
Curr Mol Pharmacol; 2023; 16(8):801-810. PubMed ID: 36578261
[TBL] [Abstract][Full Text] [Related]
14. Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
Yamaguchi F; Kamitori K; Sanada K; Horii M; Dong Y; Sui L; Tokuda M
J Biosci Bioeng; 2008 Sep; 106(3):248-52. PubMed ID: 18930000
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma.
Suzuki K; Ogawa D; Kanda T; Fujimori T; Shibayama Y; Rahman A; Ye J; Ohsaki H; Akimitsu K; Izumori K; Tamiya T; Nishiyama A; Miyake K
Sci Rep; 2023 Nov; 13(1):19515. PubMed ID: 37945736
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the inhibitory mechanism of D-allose on MOLT-4F leukemia cell proliferation.
Hirata Y; Saito M; Tsukamoto I; Yamaguchi F; Sui L; Kamitori K; Dong Y; Uehara E; Konishi R; Janjua N; Tokuda M
J Biosci Bioeng; 2009 May; 107(5):562-8. PubMed ID: 19393559
[TBL] [Abstract][Full Text] [Related]
17. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
19. Development of a d-allose-6-phosphate derivative with anti-proliferative activity against a human leukemia MOLT-4F cell line.
Ishiyama H; Yanagita RC; Takemoto K; Kobashi K; Sugiyama Y; Kawanami Y
Carbohydr Res; 2020 Jan; 487():107859. PubMed ID: 31751780
[TBL] [Abstract][Full Text] [Related]
20. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab.
Li X; Lu Y; Lu H; Luo J; Hong Y; Fan Z
Oncotarget; 2015 May; 6(13):11507-18. PubMed ID: 25871473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
